T1	Observation 25 34	CAC score
E1	Observation:T1 Name:T2 Eq-Comparison:E2
T2	Observation-Name 25 34	CAC score
A1	Observation-Type-Value T2 clinical-score
T3	Eq-Comparison 35 38	>10
E2	Eq-Comparison:T3 Operator:T4 Value:T5
T4	Eq-Operator 35 36	>
A2	Eq-Operator-Value T4 GT
T5	Eq-Value 36 38	10
T6	Eq-Comparison 67 80	10 % or above
E3	Eq-Comparison:T6 Value:T9 Unit:T10 Operator:T11
T7	Observation 44 65	Framingham risk score
E4	Observation:T7 Name:T8 Eq-Comparison:E3
T8	Observation-Name 44 65	Framingham risk score
A3	Observation-Type-Value T8 measurement
T9	Eq-Value 67 69	10
T10	Eq-Unit 70 71	%
T11	Eq-Operator 72 80	or above
A4	Eq-Operator-Value T11 GTEQ
T12	Drug 137 148	medications
E5	Drug:T12 Stability:T13 Duration:E7
T13	Stability 118 124	stable
A5	Stability-Value T13 stable
T14	Modifier 125 136	concomitant
E6	Modifier:T14 Modifies:E5
T15	Eq-Comparison 153 170	at least 12 weeks
E7	Eq-Comparison:T15 Operator:T16 Temporal-Unit:T18 Value:T17
T16	Eq-Operator 153 161	at least
A6	Eq-Operator-Value T16 GTEQ
T17	Eq-Value 162 164	12
T18	Eq-Temporal-Unit 165 170	weeks
A7	Eq-Temporal-Unit-Value T18 week
T19	Study 180 193	randomization
E8	Study:T19 
T20	Temporal-Connection 171 179	prior to
E9	Temporal-Connection:T20 Arg:E7 Arg2:E8
A8	Temporal-Connection-Type-Value E9 before
T21	Condition 213 221	diabetic
E10	Condition:T21 Name:T22
T22	Condition-Name 213 221	diabetic
T23	Observation 232 237	HbA1C
E11	Observation:T23 Name:T24 Eq-Comparison:E12
T24	Observation-Name 232 237	HbA1C
A9	Observation-Type-Value T24 lab
T25	Eq-Comparison 238 243	< 8.0
E12	Eq-Comparison:T25 Operator:T26 Value:T27
R1	If-Then Arg1:E10 Arg2:E11	
T26	Eq-Operator 238 239	<
A10	Eq-Operator-Value T26 LT
T27	Eq-Value 240 243	8.0
T28	Observation 256 261	HbA1C
E13	Observation:T28 Name:T29 Stability:T30 Eq-Comparison:E15 Duration:E17
T29	Observation-Name 256 261	HbA1C
A11	Observation-Type-Value T29 lab
T30	Stability 249 255	stable
A12	Stability-Value T30 stable
T31	And 245 248	and
E14	And:T31 Arg:E11 Arg2:E13
T32	Eq-Comparison 284 295	within 0.5%
E15	Eq-Comparison:T32 Operator:T33 Value:T34 Unit:T35
T33	Eq-Operator 284 290	within
A13	Eq-Operator-Value T33 LTEQ
T34	Eq-Value 291 294	0.5
T35	Eq-Unit 294 295	%
T36	Modifier 268 283	variation range
E16	Modifier:T36 Modifies:T29
T37	Eq-Comparison 300 312	three months
E17	Eq-Comparison:T37 Value:T38 Temporal-Unit:T39
T38	Eq-Value 300 305	three
T39	Eq-Temporal-Unit 306 312	months
A14	Eq-Temporal-Unit-Value T39 month
T40	Condition 339 355	Hypersensitivity
E18	Condition:T40 Name:T41
T41	Condition-Name 339 355	Hypersensitivity
T42	Procedure 359 370	AGE therapy
E19	Procedure:T42 Name:T43
T43	Procedure-Name 359 370	AGE therapy
R2	Caused-By Arg1:E18 Arg2:E19	
T44	Stability 377 385	Unstable
A15	Stability-Value T44 change
T45	Condition 427 435	disorder
E20	Condition:T45 Name:T46 Stability:T44
T46	Condition-Name 427 435	disorder
T47	Modifier 411 426	substance abuse
E21	Modifier:T47 Modifies:T46
T48	Modifier 395 406	psychiatric
E22	Modifier:T48 Modifies:T46
T49	Modifier 386 393	medical
E23	Modifier:T49 Modifies:T46
T50	Or 408 410	or
E24	Or:T50 Arg:E22 Arg2:E21
T51	Study 480 485	study
E25	Study:T51 Stability:T52
T52	Stability 445 454	interfere
A16	Stability-Value T52 change
T53	Assertion 441 444	may
E26	Assertion:T53 Asserted:T52
A17	Assertion-Type-Value E26 hypothetical
R3	Caused-By Arg1:T52 Arg2:E20	
T54	Observation 492 498	Weight
E27	Observation:T54 Name:T55 Eq-Comparison:E28
T55	Observation-Name 492 498	Weight
A18	Observation-Type-Value T55 vital
T56	Eq-Comparison 499 510	≥325 pounds
E28	Eq-Comparison:T56 Operator:T57 Value:T58 Unit:T59
T57	Eq-Operator 499 500	≥
A19	Eq-Operator-Value T57 GTEQ
T58	Eq-Value 500 503	325
T59	Eq-Unit 504 510	pounds
T60	Condition 517 534	Bleeding disorder
E29	Condition:T60 Name:T61
T61	Condition-Name 517 534	Bleeding disorder
T62	Condition 552 573	myocardial infarction
E30	Condition:T62 Name:T63 Temporality:E31
T63	Condition-Name 552 573	myocardial infarction
T64	Eq-Comparison 541 548	History
E31	Eq-Comparison:T64 Temporal-Period:T65
T65	Eq-Temporal-Period 541 548	History
A20	Eq-Temporal-Period-Value T65 past
T66	Condition 580 586	Stroke
E32	Condition:T66 Name:T67
T67	Condition-Name 580 586	Stroke
T68	Death 592 608	Life-threatening
E33	Death:T68 
T69	Risk 592 608	Life-threatening
E34	Risk:T69 Risk-For:E33
T70	Condition 609 619	arrhythmia
E35	Condition:T70 Name:T71 Temporality:E36
T71	Condition-Name 609 619	arrhythmia
T72	Eq-Comparison 620 641	within prior 6 months
E36	Eq-Comparison:T72 Operator:T73 Temporal-Period:T74 Value:T75 Temporal-Unit:T76
T73	Eq-Operator 620 626	within
A21	Eq-Operator-Value T73 LTEQ
T74	Eq-Temporal-Period 627 632	prior
A22	Eq-Temporal-Period-Value T74 past
T75	Eq-Value 633 634	6
T76	Eq-Temporal-Unit 635 641	months
A23	Eq-Temporal-Unit-Value T76 month
R4	Caused-By Arg1:E34 Arg2:E35	
T77	Condition 656 667	hypotension
E37	Condition:T77 Name:T78
T78	Condition-Name 656 667	hypotension
T79	Modifier 648 655	Resting
E38	Modifier:T79 Modifies:T78
T80	Observation 669 677	systolic
E39	Observation:T80 Name:T81 Eq-Comparison:E40
T81	Observation-Name 669 677	systolic
A24	Observation-Type-Value T81 vital
T82	Eq-Comparison 678 687	< 90 mmHg
E40	Eq-Comparison:T82 Operator:T83 Value:T84 Unit:T85
T83	Eq-Operator 678 679	<
A25	Eq-Operator-Value T83 LT
T84	Eq-Value 680 682	90
T85	Eq-Unit 683 687	mmHg
T86	Condition 692 704	hypertension
E41	Condition:T86 Name:T87
T87	Condition-Name 692 704	hypertension
T88	Or 689 691	or
E42	Or:T88 Arg:E37 Arg2:E41
R5	Equivalent-To Arg1:E39 Arg2:E37	
T89	Observation 714 728	blood pressure
E43	Observation:T89 Name:T90 Eq-Comparison:E45
T90	Observation-Name 714 728	blood pressure
A26	Observation-Type-Value T90 vital
T91	Modifier 706 713	resting
E44	Modifier:T91 Modifies:T90
R6	Equivalent-To Arg1:E43 Arg2:E41	
T92	Eq-Comparison 729 737	>170/110
E45	Eq-Comparison:T92 Operator:T93 Value:T94 Value2:T95
T93	Eq-Operator 729 730	>
A27	Eq-Operator-Value T93 GT
T94	Eq-Value 730 733	170
T95	Eq-Value 734 737	110
T96	Condition 744 757	Heart failure
E46	Condition:T96 Name:T97
T97	Condition-Name 744 757	Heart failure
T98	Condition 758 768	NYHA class
E47	Condition:T98 Name:T99 Stage:E48
T99	Condition-Name 758 768	NYHA class
T100	Eq-Comparison 769 778	III or IV
E48	Eq-Comparison:T100 Value:T101 Value2:T102
T101	Eq-Value 769 772	III
T102	Eq-Value 776 778	IV
T103	Condition 796 806	malignancy
E49	Condition:T103 Name:T104 Temporality:E50 Temporality2:E51
T104	Condition-Name 796 806	malignancy
T105	Eq-Comparison 785 792	History
E50	Eq-Comparison:T105 Temporal-Period:T106
T106	Eq-Temporal-Period 785 792	History
A28	Eq-Temporal-Period-Value T106 past
T107	Eq-Comparison 807 830	within the last 5 years
E51	Eq-Comparison:T107 Operator:T108 Temporal-Period:T109 Value:T110 Temporal-Unit:T111
T108	Eq-Operator 807 813	within
A29	Eq-Operator-Value T108 LTEQ
T109	Eq-Temporal-Period 818 822	last
A30	Eq-Temporal-Period-Value T109 past
T110	Eq-Value 823 824	5
T111	Eq-Temporal-Unit 825 830	years
A31	Eq-Temporal-Unit-Value T111 year
T112	Exception 832 842	other than
E52	Exception:T112 From:E49 Except:E54
T113	Modifier 843 847	skin
E53	Modifier:T113 Modifies:T115
T114	Condition 848 854	cancer
E54	Condition:T114 Name:T115
T115	Condition-Name 848 854	cancer
T116	Condition 878 884	cancer
E55	Condition:T116 Name:T117 Temporality:E56
T117	Condition-Name 878 884	cancer
T118	Eq-Comparison 871 877	active
E56	Eq-Comparison:T118 Temporal-Period:T119
T119	Eq-Temporal-Period 871 877	active
A32	Eq-Temporal-Period-Value T119 present
T120	Or 856 858	or
E57	Or:T120 Arg:E49 Arg2:E55
T121	Procedure 917 936	cancer chemotherapy
E58	Procedure:T121 Name:T122
T122	Procedure-Name 917 936	cancer chemotherapy
T123	Modifier 905 916	concomitant
E59	Modifier:T123 Modifies:T122
T124	Assertion 891 904	would require
E60	Assertion:T124 Asserted:E58
A33	Assertion-Type-Value E60 hypothetical
R7	Treatment-For Arg1:E58 Arg2:E55	
T125	Observation 942 958	Serum creatinine
E61	Observation:T125 Name:T126 Eq-Comparison:E62
T126	Observation-Name 942 958	Serum creatinine
A34	Observation-Type-Value T126 lab
T127	Eq-Comparison 959 969	>1.4 mg/dl
E62	Eq-Comparison:T127 Operator:T128 Value:T129 Unit:T130 Per:T131
T128	Eq-Operator 959 960	>
A35	Eq-Operator-Value T128 GT
T129	Eq-Value 960 963	1.4
T130	Eq-Unit 964 966	mg
T131	Eq-Unit 967 969	dl
T132	Observation 975 988	Triglycerides
E63	Observation:T132 Name:T133 Eq-Comparison:E64
T133	Observation-Name 975 988	Triglycerides
A36	Observation-Type-Value T133 lab
T134	Eq-Comparison 989 994	> 400
E64	Eq-Comparison:T134 Operator:T135 Value:T136
T135	Eq-Operator 989 990	>
A37	Eq-Operator-Value T135 GT
T136	Eq-Value 991 994	400
T137	Study 998 1006	baseline
E65	Study:T137 
T138	Temporal-Connection 995 997	at
E66	Temporal-Connection:T138 Arg:E63 Arg2:E65
A38	Temporal-Connection-Type-Value E66 during
T139	Condition 1018 1026	Diabetic
E67	Condition:T139 Name:T140
T140	Condition-Name 1018 1026	Diabetic
T141	Observation 1041 1046	HbA1C
E68	Observation:T141 Name:T142 Eq-Comparison:E69
T142	Observation-Name 1041 1046	HbA1C
A39	Observation-Type-Value T142 lab
R8	If-Then Arg1:E67 Arg2:E68	
T143	Eq-Comparison 1047 1052	> 8 %
E69	Eq-Comparison:T143 Operator:T144 Value:T145 Unit:T146
T144	Eq-Operator 1047 1048	>
A40	Eq-Operator-Value T144 GT
T145	Eq-Value 1049 1050	8
T146	Eq-Unit 1051 1052	%
T147	Condition 1075 1080	abuse
E70	Condition:T147 Name:T148
T148	Condition-Name 1075 1080	abuse
T149	Modifier 1067 1074	alcohol
E71	Modifier:T149 Modifies:T148
T150	Modifier 1059 1063	Drug
E72	Modifier:T150 Modifies:T148
T151	Or 1064 1066	or
E73	Or:T151 Arg:E72 Arg2:E71
T152	Condition 1086 1096	Conditions
E74	Condition:T152 
T153	Condition 1137 1159	coronary calcification
E75	Condition:T153 Name:T154 Stability:T155
T154	Condition-Name 1137 1159	coronary calcification
T155	Stability 1097 1108	interfering
A41	Stability-Value T155 change
R9	Caused-By Arg1:T155 Arg2:E74	
T156	Condition 1161 1172	metal clips
E76	Condition:T156 Name:T157
T157	Condition-Name 1161 1172	metal clips
R10	Example-Of Arg1:E76 Arg2:E74	
T158	Procedure 1174 1180	bypass
E77	Procedure:T158 Name:T159
T159	Procedure-Name 1174 1180	bypass
R11	Example-Of Arg1:E77 Arg2:E74	
T160	Procedure 1191 1211	intracoronary stents
E78	Procedure:T160 Name:T161
T161	Procedure-Name 1191 1211	intracoronary stents
R12	Example-Of Arg1:E78 Arg2:E74	
T162	Condition 1217 1232	drug absorption
E79	Condition:T162 Name:T163 Stability:T155
T163	Condition-Name 1217 1232	drug absorption
T164	Or 1213 1216	and
E80	Or:T164 Arg:E75 Arg2:E79
T165	Procedure 1234 1254	partial ileal bypass
E81	Procedure:T165 Name:T166
T166	Procedure-Name 1234 1254	partial ileal bypass
R13	Example-Of Arg1:E81 Arg2:E74	
T167	Condition 1258 1280	malabsorption syndrome
E82	Condition:T167 Name:T168
T168	Condition-Name 1258 1280	malabsorption syndrome
R14	Example-Of Arg1:E82 Arg2:E74	
T169	Or 1255 1257	or
E83	Or:T169 Arg:E81 Arg2:E82
T170	Eq-Comparison 1288 1295	Current
E84	Eq-Comparison:T170 Temporal-Period:T171
T171	Eq-Temporal-Period 1288 1295	Current
A42	Eq-Temporal-Period-Value T171 present
T172	Drug 1303 1317	anticoagulants
E85	Drug:T172 Name:T173 Temporality:E84
T173	Drug-Name 1303 1317	anticoagulants
T174	Exception 1319 1329	except for
E86	Exception:T174 From:E85 Except:E87
T175	Drug 1330 1349	antiplatelet agents
E87	Drug:T175 Name:T176
T176	Drug-Name 1330 1349	antiplatelet agents
T177	Condition 1364 1377	renal failure
E88	Condition:T177 Name:T178
T178	Condition-Name 1364 1377	renal failure
T179	Modifier 1356 1363	Chronic
E89	Modifier:T179 Modifies:T178
T180	Condition 1383 1396	Liver failure
E90	Condition:T180 Name:T181
T181	Condition-Name 1383 1396	Liver failure
T182	Observation 1431 1437	values
E91	Observation:T182 Name:T183 Polarity:T189 Severity:T190
T183	Observation-Name 1431 1437	values
A43	Observation-Type-Value T183 lab
T184	Modifier 1419 1430	biochemical
E92	Modifier:T184 Modifies:T183
T185	Modifier 1402 1415	Hematological
E93	Modifier:T185 Modifies:T183
T186	Or 1416 1418	or
E94	Or:T186 Arg:E93 Arg2:E92
T187	Study 1441 1449	baseline
E95	Study:T187 
T188	Temporal-Connection 1438 1440	at
E96	Temporal-Connection:T188 Arg:E91 Arg2:E95
A44	Temporal-Connection-Type-Value E96 during
T189	Polarity 1456 1484	outside the reference ranges
A45	Polarity-Value T189 abnormal
T190	Severity 1510 1521	significant
A46	Severity-Value T190 severe
